Exagen inc. announces new pla code and medicare pricing for proprietary avise® lupus test

San diego, may 11, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, announced today that medicare administrative contractor (mac) noridian has provided pricing for avise® lupus. noridian's decision to price avise lupus follows the approval by the american medical association (ama) cpt® editorial panel of proprietary laboratory code (pla) code 0312u for avise lupus. the pla code has an effective date of april 1, 2022.
XGN Ratings Summary
XGN Quant Ranking